<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Secretin
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Secretin
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Secretin
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rodger A Liddle, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            J Thomas Lamont, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 15, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The field of endocrinology and the study of "hormones" began at the turn of the 20
         <sup>
          th
         </sup>
         century when Bayliss and Starling described a chemical substance in intestinal extracts that, when injected intravenously, stimulated pancreatic secretion [
         <a href="#rid1">
          1
         </a>
         ]. They named this substance
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         because it caused the pancreas to secrete fluid when acid was present in the gut. This discovery led to a search for other chemical substances that when released from one tissue could excite or stimulate organ function in a different location. The Greek word "hormone," meaning "arise to activity," was used to designate these chemical messengers. It is now known that secretin stimulates pancreatic fluid and bicarbonate secretion leading to neutralization of acidic chyme in the intestine. Secretin also inhibits gastric acid release and intestinal motility.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MOLECULAR FORMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite knowledge of physiological activity, it took more than 50 years for the chemical nature of the hormone
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         to be identified. The amino acid sequence was not determined until the 1960s [
         <a href="#rid2">
          2
         </a>
         ]. Human secretin is a 27 amino-acid peptide, with a molecular weight of 3055 D. Its sequence is conserved across many mammalian species (
         <a class="graphic graphic_figure graphicRef58228" href="/z/d/graphic/58228.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Similar to other gastrointestinal peptides,
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         is amidated at the C-terminus. It is the founding member of the secretin/glucagon/vasoactive intestinal polypeptide family of gastrointestinal hormones. The gene structure of preprosecretin contains an N-terminal signal peptide, a short peptide sequence, secretin, and a C-terminal extension peptide [
         <a href="#rid3">
          3
         </a>
         ]. The gene encoding secretin is selectively expressed in specialized enteroendocrine cells of the small intestine, called S cells. The details of secretin gene transcriptional control have been studied in secretin-producing islet cells [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          TISSUE DISTRIBUTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immunocytochemistry has demonstrated that secretin-producing cells are found along the small intestine (
         <a class="graphic graphic_figure graphicRef76730" href="/z/d/graphic/76730.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ]. With the exception of L cells that produce peptide YY and glucagon-like peptides, historically, it was believed that an individual enteroendocrine cell produced only one hormone. However, a number of studies using single-cell molecular profiling have demonstrated that although one hormone may predominate, an enteroendocrine cell often produces multiple different peptides. Notably,
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         appears to be expressed in virtually all enteroendocrine cells [
         <a href="#rid6">
          6
         </a>
         ] and is prominently expressed in cells that express 5-hydroxytryptamine (serotonin) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          Secretin
         </a>
         is also produced by cholangiocytes which express secretin receptors on their basolateral surfaces. Thus, through a paracrine action, secretin can stimulate ductal secretion of fluid and electrolytes [
         <a href="#rid8">
          8
         </a>
         ]. Under conditions of bile duct obstruction, secretin contributes to cholangiocyte proliferation [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         Other sites shown to produce
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         mRNA are the pancreas, heart, lung, kidney, testis and brain including the hypothalamus, cortex, cerebellum, and brainstem [
         <a href="#rid3">
          3,10,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          RECEPTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         receptor is a member of the family of G protein-coupled receptors (GPCRs), within which the secretin/glucagon family is structurally unique. This group consists of receptors for secretin, glucagon, calcitonin, parathyroid hormone, pituitary adenylyl cyclase-activating peptide (PACAP), vasoactive intestinal polypeptide, and others. These receptors lack structural signature sequences present in the rhodopsin/beta-adrenergic receptor family (such as a DRY motif — Asp-Arg-Tyr — at the end of the third transmembrane spanning domain), which appear to be important in receptor coupling to G proteins. Secretin binds to its specific heptahelical membrane receptor and activates the heterotrimeric G protein, Gs, leading to elevation of cellular cAMP levels. This second messenger begins the signaling cascade that initiates appropriate cell physiological responses. (See
         <a class="medical medical_review" href="/z/d/html/3804.html" rel="external">
          "Peptide hormone signal transduction and regulation"
         </a>
         .)
        </p>
        <p>
         The mechanisms for
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         receptor signal termination involve receptor phosphorylation [
         <a href="#rid12">
          12
         </a>
         ], mediated by GPCR kinases [
         <a href="#rid13">
          13
         </a>
         ]. The mechanism for secretin receptor internalization is distinct from that used by prototypical Class I GPCRs [
         <a href="#rid14">
          14
         </a>
         ]. The specific mechanism for receptor internalization suggests that novel proteins may be involved in its regulation.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          Secretin
         </a>
         receptors are abundant on duct and acinar cells of the pancreas, where they mediate secretin-stimulated fluid and bicarbonate secretion and may potentiate cholecystokinin- and acetylcholine-stimulated enzyme secretion. Secretin receptors are also present in cholangiocytes, kidney, brain cells, sensory neurons in the vagus nerve, and endocrine and other cells of the gastrointestinal tract [
         <a href="#rid15">
          15,16
         </a>
         ]. It is possible the secretin and cholecystokinin receptors on vagal sensory neurons synergistically enhance postprandial pancreatic enzyme secretion [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          Secretin
         </a>
         receptors are also found on some tumors of the gastrointestinal tract. Alternative splicing of secretin receptor pre-mRNA in such tumors may be biologically important for understanding the function of the receptor and in developing potential chemotherapeutic targets [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          SECRETIN RELEASE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major physiological actions of
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         are stimulation of pancreatic fluid and bicarbonate secretion. Bicarbonate, upon reaching the duodenum, neutralizes gastric acid and raises the duodenal pH, thereby "turning off" secretin release via a negative feedback mechanism [
         <a href="#rid19">
          19
         </a>
         ]. It has been suggested that acid-stimulated secretin release is regulated by an endogenous intestinal secretin-releasing factor (SRF) (
         <a class="graphic graphic_figure graphicRef74092" href="/z/d/graphic/74092.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid20">
          20
         </a>
         ]. This peptide stimulates secretin until the flow of pancreatic proteases is sufficient to degrade the releasing factor and terminate secretin release. Confirmation of this negative feedback pathway awaits identification of the putative SRF.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          PHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the primary action of
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         is to produce pancreatic fluid and bicarbonate secretion [
         <a href="#rid21">
          21
         </a>
         ], it is also an enterogastrone (a substance that is released when fat is ingested that inhibits gastric acid secretion). In physiological concentrations, secretin inhibits gastric acid release, gastric motility, and gastrin release [
         <a href="#rid22">
          22
         </a>
         ]. Similar to other hormones released from the upper small intestine, like cholecystokinin, secretin slows the rate of gastric emptying [
         <a href="#rid23">
          23
         </a>
         ]. When studied using pharmacologic doses, secretin also increases bile flow, gastrointestinal motility, and lower esophageal sphincter pressure, and stimulates insulin release following the ingestion of glucose [
         <a href="#rid15">
          15,24-26
         </a>
         ].
        </p>
        <p>
         Many studies suggest that
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         can promote growth of the pancreas [
         <a href="#rid27">
          27
         </a>
         ]. This latter finding has raised speculation that secretin may contribute to pancreatic cancer [
         <a href="#rid28">
          28
         </a>
         ]. However, direct evidence for secretin in the pathogenesis of pancreatic cancer is currently lacking. Interestingly, targeted ablation (knockout) of secretin-producing cells in transgenic mice resulted in an animal devoid of many enteroendocrine cells, suggesting that secretin expression may be necessary at an early step in the development of gut endocrine cells [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         Like several other gut peptides,
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         has anorectic properties when administered centrally or peripherally [
         <a href="#rid30">
          30
         </a>
         ]. The central effects of secretin on satiety are mediated by the melanocortin system. The satiety-inducing effects of peripherally administered secretin are blocked by vagotomy or ablating sensory nerves with
         <a class="drug drug_general" data-topicid="8840" href="/z/d/drug information/8840.html" rel="external">
          capsaicin
         </a>
         , indicating that secretin signals through the sensory fibers of the vagus nerve [
         <a href="#rid31">
          31
         </a>
         ]. Following Roux-en-Y gastric bypass surgery (RYGB), secretin levels more than double [
         <a href="#rid32">
          32
         </a>
         ]. Although the satiety effects of secretin are relatively weak compared with other gut peptides such as cholecystokinin or peptide YY, its action on the vagus nerve may contribute to the reductions in food intake following RYGB.
        </p>
        <p>
         It has been demonstrated that
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         activates brown fat and mediates meal-associated thermogenesis that causes meal termination [
         <a href="#rid33">
          33-35
         </a>
         ]. Therefore, secretin appears to provide a physiologically relevant satiation signal.
        </p>
        <p>
         The physiologic role of
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         in the brain is incompletely understood, although it may act as a neuropeptide. Impaired synaptic plasticity and antisocial behavior has been observed in secretin-receptor-deficient mice [
         <a href="#rid36">
          36
         </a>
         ]. During development, secretin has neurotrophic effects on serotoninergic mesencephalic neurons, and these effects are lost in neurodegenerative diseases [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL USES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common clinical application of
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         is in the diagnosis of gastrin-secreting tumors. Under normal conditions, secretin administration inhibits gastrin release (see
         <a class="local">
          'Physiology'
         </a>
         above). However, in gastrinomas, injection of secretin causes a paradoxical increase in gastrin release. This pathophysiological phenomenon is the basis for the secretin stimulation test. This test is a safe, effective, and reliable method for determining the presence of a gastrin-producing tumor (
         <a class="graphic graphic_table graphicRef64937" href="/z/d/graphic/64937.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid38">
          38,39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2627.html" rel="external">
          "Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Due to its effect on pancreatic exocrine secretion,
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         has been used clinically to diagnose pancreatic insufficiency [
         <a href="#rid40">
          40,41
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4780.html" rel="external">
          "Approach to the adult patient with suspected malabsorption"
         </a>
         ). Acute administration of secretin causes temporary dilation of pancreatic ducts by increasing pancreatic secretions. This pharmacologic effect is the basis for administration of secretin during endoscopic retrograde cholangiopancreatography to aid in ductal cannulation (primarily the minor duct) (see
         <a class="medical medical_review" href="/z/d/html/5653.html" rel="external">
          "Pancreas divisum: Clinical manifestations and diagnosis"
         </a>
         ). In addition, secretin has been used in magnetic resonance imaging of the pancreas during functional testing to evaluate pancreatic secretion and ductal obstruction [
         <a href="#rid42">
          42,43
         </a>
         ]. Secretin-enhanced magnetic resonance cholangiopancreatography is particularly useful to detect and diagnose congenital, inflammatory, and neoplastic conditions of the pancreas and may be more useful than standard magnetic resonance imaging to evaluate subtle changes in chronic pancreatitis [
         <a href="#rid44">
          44,45
         </a>
         ]. In addition, secretin administration appears to accentuate regions of pancreatic vascular hypoperfusion [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Anecdotal reports suggest that
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         administration might be an effective treatment for autism spectrum disorders. However, these early reports have not been validated in randomized controlled trials and secretin is not recommended for treatment of autism [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          Secretin
         </a>
         is a 27 amino-acid peptide produced by cells in the small intestine, hypothalamus, cortex, cerebellum, and brainstem. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Molecular forms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          Secretin
         </a>
         receptors are abundant on duct and acinar cells of the pancreas, where they mediate secretin-stimulated fluid and bicarbonate secretion leading to neutralization of acidic chyme in the intestine and may potentiate cholecystokinin- and acetylcholine-stimulated enzyme secretion. (See
         <a class="local">
          'Tissue distribution'
         </a>
         above and
         <a class="local">
          'Receptors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most common clinical application of
         <a class="drug drug_general" data-topicid="10259" href="/z/d/drug information/10259.html" rel="external">
          secretin
         </a>
         is in the diagnosis of gastrin-secreting tumors. Under normal conditions, secretin administration inhibits gastrin release. However, in gastrinomas, injection of secretin causes a paradoxical increase in gastrin release. This pathophysiological phenomenon is the basis for the secretin stimulation test. (See
         <a class="local">
          'Physiology'
         </a>
         above and
         <a class="local">
          'Clinical uses'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902; 28:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mutt V, Jorpes JE, Magnusson S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970; 15:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kopin AS, Wheeler MB, Leiter AB. Secretin: structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 1990; 87:2299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishitani J, Rindi G, Lopez MJ, et al. Transcriptional regulation of secretin gene expression. J Clin Gastroenterol 1995; 21 Suppl 1:S50.
          </a>
         </li>
         <li class="breakAll">
          Leiter AB, Chey WY, Kopin AS. Secretin, 1st ed, Raven Press, New York 1994.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haber AL, Biton M, Rogel N, et al. A single-cell survey of the small intestinal epithelium. Nature 2017; 551:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fazio Coles TE, Fothergill LJ, Hunne B, et al. Quantitation and chemical coding of enteroendocrine cell populations in the human jejunum. Cell Tissue Res 2020; 379:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marinelli RA, Pham L, Agre P, LaRusso NF. Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane. Evidence for a secretin-induced vesicular translocation of aquaporin-1. J Biol Chem 1997; 272:12984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaser S, Meng F, Han Y, et al. Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. Gastroenterology 2014; 146:1795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SM, Yung WH, Chen L, Chow BK. Expression and spatial distribution of secretin and secretin receptor in human cerebellum. Neuroreport 2005; 16:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohta M, Funakoshi S, Kawasaki T, Itoh N. Tissue-specific expression of the rat secretin precursor gene. Biochem Biophys Res Commun 1992; 183:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozcelebi F, Holtmann MH, Rentsch RU, et al. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. Mol Pharmacol 1995; 48:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shetzline MA, Premont RT, Walker JK, et al. A role for receptor kinases in the regulation of class II G protein-coupled receptors. Phosphorylation and desensitization of the secretin receptor. J Biol Chem 1998; 273:6756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker JK, Premont RT, Barak LS, et al. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor. J Biol Chem 1999; 274:31515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Afroze S, Meng F, Jensen K, et al. The physiological roles of secretin and its receptor. Ann Transl Med 2013; 1:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bai JJ, Tan CD, Chow BKC. Secretin, at the hub of water-salt homeostasis. Am J Physiol Renal Physiol 2017; 312:F852.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y. Sensory signal transduction in the vagal primary afferent neurons. Curr Med Chem 2007; 14:2554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Körner M, Miller LJ. Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors. Am J Pathol 2009; 175:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaffalitzky de Muckadell OB, Fahrenkrug J. Secretion pattern of secretin in man: regulation by gastric acid. Gut 1978; 19:812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li P, Lee KY, Chang TM, Chey WY. Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. J Clin Invest 1990; 86:1474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           You CH, Rominger JM, Chey WY. Effects of atropine on the action and release of secretin in humans. Am J Physiol 1982; 242:G608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           You CH, Chey WY. Secretin is an enterogastrone in humans. Dig Dis Sci 1987; 32:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandler J, Miller LJ, Wang XJ, et al. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial. Am J Physiol Gastrointest Liver Physiol 2020; 318:G635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyer JL, Bloomer JR. Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol. J Clin Invest 1974; 54:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinoso VP Jr, Meshkinpour H, Lorber SH, et al. Motor responses of the sigmoid colon and rectum to exogenous cholecystokinin and secretin. Gastroenterology 1973; 65:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen S, Lipshutz W. Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin. J Clin Invest 1971; 50:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomon TE, Vanier M, Morisset J. Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol 1983; 245:G99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Talamini G. Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis. JOP 2005; 6:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rindi G, Ratineau C, Ronco A, et al. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development 1999; 126:4149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng CY, Chu JY, Chow BK. Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology 2011; 36:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu JY, Cheng CY, Sekar R, Chow BK. Vagal afferent mediates the anorectic effect of peripheral secretin. PLoS One 2013; 8:e64859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Modvig IM, Andersen DB, Grunddal KV, et al. Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine. Int J Obes (Lond) 2020; 44:1859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Schnabl K, Gabler SM, et al. Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation. Cell 2018; 175:1561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schnabl K, Li Y, Klingenspor M. The gut hormone secretin triggers a gut-brown fat-brain axis in the control of food intake. Exp Physiol 2020; 105:1206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laurila S, Sun L, Lahesmaa M, et al. Secretin activates brown fat and induces satiation. Nat Metab 2021; 3:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishijima I, Yamagata T, Spencer CM, et al. Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. Hum Mol Genet 2006; 15:3241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lossi L, Bottarelli L, Candusso ME, et al. Transient expression of secretin in serotoninergic neurons of mouse brain during development. Eur J Neurosci 2004; 20:3259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGuigan JE, Wolfe MM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 1980; 79:1324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brady CE 3rd. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol 1991; 86:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catalano MF, Lahoti S, Geenen JE, Hogan WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998; 48:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raimondo M, Imoto M, DiMagno EP. Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls. Clin Gastroenterol Hepatol 2003; 1:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalid A, Peterson M, Slivka A. Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: a pilot study. Dig Dis Sci 2003; 48:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monill J, Pernas J, Clavero J, et al. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography. AJR Am J Roentgenol 2004; 183:1267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akisik MF, Sandrasegaran K, Aisen AA, et al. Dynamic secretin-enhanced MR cholangiopancreatography. Radiographics 2006; 26:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balci NC, Alkaade S, Magas L, et al. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J Magn Reson Imaging 2008; 27:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bali MA, Metens T, Denolin V, et al. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results. Radiology 2008; 247:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams K, Wray JA, Wheeler DM. Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012; :CD003495.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2560 Version 13.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16992627" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The mechanism of pancreatic secretion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5465996" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Structure of porcine secretin. The amino acid sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2315322" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Secretin: structure of the precursor and tissue distribution of the mRNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8774991" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Transcriptional regulation of secretin gene expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8774991" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Transcriptional regulation of secretin gene expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29144463" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : A single-cell survey of the small intestinal epithelium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31478137" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Quantitation and chemical coding of enteroendocrine cell populations in the human jejunum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9148905" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane. Evidence for a secretin-induced vesicular translocation of aquaporin-1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24583060" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15706223" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Expression and spatial distribution of secretin and secretin receptor in human cerebellum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1550548" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Tissue-specific expression of the rat secretin precursor gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7476911" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506976" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A role for receptor kinases in the regulation of class II G protein-coupled receptors. Phosphorylation and desensitization of the secretin receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10531354" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25332973" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The physiological roles of secretin and its receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27279485" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Secretin, at the hub of water-salt homeostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17979708" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Sensory signal transduction in the vagal primary afferent neurons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19574427" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30682" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Secretion pattern of secretin in man: regulation by gastric acid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2243126" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7091334" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Effects of atropine on the action and release of secretin in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2952476" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Secretin is an enterogastrone in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32036693" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4610005" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4728978" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Motor responses of the sigmoid colon and rectum to exogenous cholecystokinin and secretin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5540178" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6191579" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cell site and time course of DNA synthesis in pancreas after caerulein and secretin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15767727" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10457023" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20927047" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23738005" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Vagal afferent mediates the anorectic effect of peripheral secretin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32015474" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30449620" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32271980" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The gut hormone secretin triggers a gut-brown fat-brain axis in the control of food intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34158656" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Secretin activates brown fat and induces satiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17008357" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15610158" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Transient expression of secretin in serotoninergic neurons of mouse brain during development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7439637" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Secretin injection test in the diagnosis of gastrinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1992623" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9684658" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15017660" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12924639" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15505290" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702446" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Dynamic secretin-enhanced MR cholangiopancreatography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18058927" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18292476" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513913" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Intravenous secretin for autism spectrum disorders (ASD).
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
